Two early-career scientists have each been awarded a one-year, $30,000 American Cancer Society Institutional Research Grant through Holden Comprehensive Cancer Center at the UI.

These seed grants help junior faculty members and independent research scientists start their careers in cancer research, and provide funds to explore new ideas related to the cause, prevention, and treatment of cancer. This is the first round of awards made within the current grant period.

New grant recipients

Vignesh Packiam, MD, Clinical Assistant Professor, Department of Urology
Project: An Open-Label, Single-Arm, Phase II Study of Sequential Intravesical Gemcitabine and Docetaxel (Gem/Doce) for BCG-Naïve High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)

Suresh Veeramani, DVM, PhD, Research Assistant Professor, Department of Internal Medicine
Project: Specific T Regulatory Cell Inhibition with Novel Astamer-siRNA Chimeric Molecules